Xcout Intel
Kaleo Communications, Inc.
Kaléo Communications develops drug-device combination products and auto-injector technologies, including the Aerio platform. The company provides customized drug-delivery devices and marketed auto-injector medicines for patients, caregivers, pharmaceutical partners, and government agencies to address urgent medical needs such as anaphylaxis and emergency countermeasures.
Subscribe to see Kaleo Communications, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kaleo Communications, Inc. at a glance
Kaleo Communications, Inc. is a pharmaceuticals company headquartered in United States. It has raised at least $8.5M across the 3 funding rounds on record. Its most recent funding round raised $20,000 in May 2017. Xcout tracks 13 named people at Kaleo Communications, Inc., including Michael Wells (Chairman & Chief Executive Officer). Xcout recorded 7 job postings from Kaleo Communications, Inc. in the last 90 days.
Kaleo Communications, Inc. leadership
- Michael WellsChairman & Chief Executive Officer
- George PariseChief Financial Officer
- Alfred TenutoChief Commercial Officer
- Chuck NichollsChief Manufacturing and Supply Chain Officer
- Ted MarcuccioChief Business Officer
- Theresa Matkovits, Ph.D.Chief Development Officer
7 more named people on record for Kaleo Communications, Inc., with roles, board committees and tenure — see the full roster →
Kaleo Communications, Inc. funding rounds
At least $8.5M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $20,000 | — | |
| — | $7M | 6 named | |
| — | $1.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Kaleo Communications, Inc.
Xcout recorded 7 job postings from Kaleo Communications, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Kaleo Communications, Inc.'s hiring signals →
Investors
Kaleo Communications, Inc. competitors
A few of Kaleo Communications, Inc.'s closest competitors — see the full list of competitors and alternatives →
ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.
Crossject SA is an emerging specialty pharmaceutical company based in France and the U.S. that focuses on advanced regulatory and needle-free injection technologies. Headquartered in Dijon, France, the firm develops innovative drug delivery systems.
KiOmed Pharma is a Belgian biotechnology company that develops, manufactures, and distributes injectable medical devices based on an exclusive natural chitosan derivative called KiOmedine CM-chitosan. The company serves patients and medical professionals by creating therapeutic solutions and aesthetic products to address osteoarthritis, skin aging, and eye diseases.
MediPrint Ophthalmics is a clinical-stage eye care pharmaceutical company that develops and commercializes a proprietary ocular drug delivery portfolio. The company provides drug-eluting, comfort-enhancing contact lenses designed to offer continuous medication delivery and vision correction for patients with ocular diseases.
Biora Therapeutics is a U.S. biotechnology company developing ingestible, device-based platforms for delivering biologic medicines to targeted areas of the gastrointestinal tract and into systemic circulation. Its technologies are intended for use by pharmaceutical and biotechnology companies developing oral or targeted biologic therapies.
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for critically and chronically ill patients. Its portfolio includes intravenous drugs, clinical nutrition, medical technologies, and biopharmaceuticals designed to improve patient care and treatment efficiencies worldwide.
Get Kaleo Communications, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Kaleo Communications, Inc.? Suggest a correction · Work at Kaleo Communications, Inc.? Claim this profile
Is this your company? Add the Xcout Intel badge to your website
Free, for any company on Xcout Intel. It links visitors to this profile.
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Kaleo Communications, Inc. in Xcout Intel
- 13 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access